Lung Cancer MDT Project BHRUT Lucy Gladman – General Manager
BHRUT Lung MDT Large Acute Trust 1 st April 2014 – 31 st March 2015* Population ~ 750,000 – 303 primary patients diagnosed – 306 patients discussed at MDT – Treat 10% of London's cancers; 203 treatments – 50% of NEL’s cancers 37 monitoring 44 chemo Financially challenged 6 chemo radiotherapy 39 palliative care Special measures since January 50 surgery 2014 27 radiotherapy Staging completeness Jan – Dec 2014 – 89%** * Somerset, ** COSD
Project Objectives To establish baseline metrics; To redesign and implement an MDT model that meets the requirements of the London Cancer pathway specification; To devise a plan for monitoring and evaluating the effectiveness of the redesigned MDT; To measure and evaluate the impact and effectiveness of the revised MDT model and ensure alignment with national best practice; To use the intelligence gained to develop a “blue print” model and recommendations for wider implementation.
Project Support Two partnered Trusts to pool expertise; Supported by Medical and Educational Grant from Pfizer; Project manager appointed from Quintiles; Lead Clinician for Cancer; Lung MDT Clinical Lead; Service Manager for Respiratory; General Manager for Cancer.
Baseline Data Top priority KPIs: Time from referral to DTT; – Number of patients who go on to treatment; – Number of patients who go on to be enrolled in clinical trials; – Additional KIPs Number of new patients per MDT; – MDT attendance; – Time from referral to diagnosis; – Time from referral to staging; – Time from staging to DTT MDT; – Proportion of patients to: – Surgery Chemotherapy Palliative intervention.
Project Timeline
Workshop 7 th January 2015; 23 attendees – Physicians, Surgeon, CNS’s, MDT Coordinators, Hisptopathologist, Oncologist, Palliative Care, Radiologist, Managers 17 high level actions identified; Three overarching themes: MDT 2WW Surgery
Actions Identified Excessive workload of the lung cancer MDT and need for lung nodule MDT; CT scan required prior to first OPA; Optimise days for EBUS; Increased lung function capacity required PET scanner needed; Communication between Trusts Improved data
Actions Implemented Nodule MDT; – Protocol written; – Budget identified for admin support; – Advertised and interviewed 27 th May. – Start date TBA! To pilot nurse-led nodule service; – Business case to be developed
Actions Implemented CT scan prior to first OPA; Previous implementation put 2ww target at risk; Audit undertaken of 2 weeks of 2ww referrals; – Understand actual demand – Try to establish protocol for Cancer Referrals Office Meeting held with radiology for them to understand MDT requirement; Need to identify area for CT hydration patients
Actions Implemented Excessive workload of MDT; Audit undertaken of delayed patients due to unavailability of notes at MDT; Nodule MDT will move some workload; Inter-MDT process refined; EBUS moved to Wednesday; – Reduces number of patients not discussed at MDT; Review MDT Coordinator support; – Pool work across site; – Band 3 support to coordinate MDT agenda
Actions Implemented Enabling works for PET scanner; – Awaiting financial approval; Need business case to increase lung function test capacity; Meeting with Bart’s Health – 4 th June 2015, to improve communications; MDT received training on how to improve data quality for NLCA; Review MDT once all actions implemented.
Summary Identified short, medium and long term actions; Brought team together; Focused the actions needed; Raised profile of cancer targets with the clinicians; Identified audits to be undertaken; Project overran; – Restructure; – CQC re-visit Committed to keeping up the actions.
“If there is no struggle, there is no progress.” Frederick Douglass
Recommend
More recommend